ASNS and acute lymphoblastic leukemia: Considering the adverse effects of asparaginase [11,12], although intensified asparaginase therapy improved the therapeutic outcome of T-ALL [28], further intensification of asparaginase therapy might not be recommended in T-ALL patients with intermediately or weakly methylated status of the ASNS gene.